 The center has around 1,300 employees in "review teams" that evaluate and approve new drugs.Additionally, the CDER employs a "safety team" with 72 employees to determine whether new drugs are unsafe or present risks not disclosed in the product's labeling.The FDA's budget for approving, labeling, and monitoring drugs is roughly $290 million per year.